1-9 of 9
Jianming Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5461: H002: A wide spectrum, highly selective fourth-generation EGFR inhibitor overcoming resistance harboring C797S mutation in NSCLC

Wei Huang, Lin Zhu, Xiaoe Yan, Xin Huang, Jia Hao, Shan Li, Xiangyu Li, Zhiming Chen, Yunchuan Jia, Haibo Li, Jianming Zhang, Xianming Deng, Caihong Yun
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5461.
DOI: https://doi.org/10.1158/1538-7445.AM2022-5461
Published: 15 June 2022
View article
Journal Articles

Abstract 398: Overriding drug resistance in Philadelphia chromosome-positive acute B lymphoblastic leukemia by targeting both BCR-ABL and MAP4K signaling pathways

Ruibao Ren, Xinhua Xiao, Jianming Zhang, Bo Jiao
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 398.
DOI: https://doi.org/10.1158/1538-7445.AM2019-398
Published: 01 July 2019
View article
Journal Articles

A Novel Microtubule Inhibitor Overcomes Multidrug Resistance in Tumors

Nannan Ning, Yamei Yu, Min Wu, Ruihong Zhang, Ting Zhang, Changjun Zhu, Lei Huang, Cai-Hong Yun, Cyril H. Benes, Jianming Zhang, Xianming Deng, Qiang Chen, Ruibao Ren
Journal: Cancer Research
Cancer Res (2018) 78 (20): 5949–5957.
DOI: https://doi.org/10.1158/0008-5472.CAN-18-0455
Published: 15 October 2018
View article
PDF
Journal Articles

Abstract 3926: Discovering a novel microtubule inhibitor overcoming tumor multidrug resistance

Nannan Ning, Chengyong Wu, Min Wu, Yamei Yu, Changjun Zhu, Cyril Benes, Jianming Zhang, Xianming Deng, Qiang Chen, Ruibao Ren
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3926.
DOI: https://doi.org/10.1158/1538-7445.AM2018-3926
Published: 01 July 2018
View article
Journal Articles

Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors

Jie Jiang, Fu Gui, Zhixiang He, Li Li, Yunzhan Li, Shunying Li, Xinrui Wu, Zhou Deng, Xihuan Sun, Xiaoxing Huang, Wei Huang, Shang Han, Ting Zhang, Zheng Wang, Bo Jiao, Siyang Song, Hongrui Wang, Lanfen Chen, Dawang Zhou, Qiang Liu, Ruibao Ren, Jianming Zhang, Xianming Deng
Journal: Cancer Research
Cancer Res (2017) 77 (1): 175–186.
DOI: https://doi.org/10.1158/0008-5472.CAN-16-1038
Published: 02 January 2017
View article
PDF
Includes: Supplementary data
Journal Articles

mTORC1-Driven Tumor Cells Are Highly Sensitive to Therapeutic Targeting by Antagonists of Oxidative Stress

Jing Li, Sejeong Shin, Yang Sun, Sang-Oh Yoon, Chenggang Li, Erik Zhang, Jane Yu, Jianming Zhang, John Blenis
Journal: Cancer Research
Cancer Res (2016) 76 (16): 4816–4827.
DOI: https://doi.org/10.1158/0008-5472.CAN-15-2629
Published: 14 August 2016
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 5605: Pharmacologic inhibition of EphA2 in NRAS and BRAF mutant melanomas.

Benchun Miao, Jianming Zhang, Zhenyu Ji, Ching Ni Njauw, Michael Taylor, Raj Kumar, Nathanael Gray, Hensin Tsao
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5605.
DOI: https://doi.org/10.1158/1538-7445.AM2013-5605
Published: 15 April 2013
View article
Journal Articles

Abstract 3683: Small molecule inhibitors of the Fes non-receptor tyrosine kinase

Sabine Hellwig, Jianming Zhang, Panagis Filippakopoulos, Eidarus Salah, Stefan Knapp, Nathanael S. Gray, Thomas E. Smithgall
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3683.
DOI: https://doi.org/10.1158/1538-7445.AM10-3683
Published: 15 April 2010
View article
Journal Articles

Abstract 5578: Quantitative kinase inhibitor profiling in native cell and tissue extracts

Matthew P. Patricelli, Tyzoon K. Nomanbhoy, John W. Kozarich, Nathanael S. Gray, Jianming Zhang, Jiangyue Wu
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5578.
DOI: https://doi.org/10.1158/1538-7445.AM10-5578
Published: 15 April 2010
View article